Enhancement of anti-OVA IgG2c production in vivo by enalapril

AUTOR(ES)

Almeida, L.C., Muraro, L.S., Albuquerque, D.A.

FONTE

Braz J Med Biol Res

DATA DE PUBLICAÇÃO

11/07/2016

RESUMO

Angiotensin-converting enzyme (ACE) inhibitors have non-hemodynamic, pleiotropic effects on the immune response. The effects of ACE inhibitors on the production of cytokines and T-cell functions are well established. However, little is known on the effects of these medicines on humoral response to foreign antigens. In this study, we investigated the effect of enalapril treatment on ovalbumin (OVA)-specific IgG1 and IgG2c production in mice determined by ELISA. Two groups of 8-week-old C57BL/6 females mice (3–4/group) were subcutaneously immunized with OVA (10 μg/animal) in presence of Alhydrogel (1 mg/mouse) and boosted at day 21. The mice were treated with enalapril (5 mg/kg daily, po) or were left without treatment for one month. The animals were bled from the orbital plexus on days 0, 7, 14, 21, and 28 after the first immunization and the sera were stored at –20°C until usage. OVA-specific serum IgG1 and IgG2c were determined by ELISA using serum from each individual animal. The results showed that enalapril significantly increased anti-OVA serum IgG2c in the secondary response without affecting IgG1 synthesis. These data expand our understanding on the properties of enalapril on the immune response, including antibody production.

Documentos Relacionados

• Effect of oral administration of Propionibacterium acnes on growth performance, DTH response and anti-OVA titers in goat kids
• Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes.
• In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants.
• IgG Anti-IgE Autoantibodies in Visceral Leishmaniasis
• Production and characterization of monoclonal antibodies anti fragment Fc of bovine IgG